Effect of the lower ligand precursors on vitamin B12 production by food-grade Propionibacteria by Chamlagain, Bhawani et al.
Accepted Manuscript
Effect of the lower ligand precursors on vitamin B12 production by food-grade
propionibacteria
Bhawani Chamlagain, Paulina Deptula, Minnamari Edelmann, Susanna Kariluoto,
Franck Grattepanche, Christophe Lacroix, Pekka Varmanen, Vieno Piironen
PII: S0023-6438(16)30207-9
DOI: 10.1016/j.lwt.2016.04.023
Reference: YFSTL 5411
To appear in: LWT - Food Science and Technology
Received Date: 1 March 2016
Revised Date: 8 April 2016
Accepted Date: 15 April 2016
Please cite this article as: Chamlagain, B., Deptula, P., Edelmann, M., Kariluoto, S., Grattepanche,
F., Lacroix, C., Varmanen, P., Piironen, V., Effect of the lower ligand precursors on vitamin B12
production by food-grade propionibacteria, LWT - Food Science and Technology (2016), doi: 10.1016/
j.lwt.2016.04.023.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Effect of the lower ligand precursors on vitamin B12 production by food-1 
grade propionibacteria 2 
 3 
Bhawani Chamlagain1,*, Paulina Deptula1, Minnamari Edelmann1, Susanna 4 
Kariluoto1, Franck Grattepanche 2,3, Christophe Lacroix2, Pekka Varmanen1,Vieno 5 
Piironen1 6 
 7 
 8 
1 Department of Food and Environmental Sciences, P.O. Box 27, University of 9 
Helsinki, FI-00014 University of Helsinki, Finland 10 
2
 Laboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH 11 
Zurich, Schmelzbergstrasse 7, 8092 Zurich, Switzerland 12 
3 Current address: Research and Development Centre, Yoplait Ltd., Vienne, 13 
France 14 
 15 
 16 
 17 
*Corresponding author. Tel.: +358 2 94158249; fax: +358 2 94158475; E-mail: 18 
bhawani.chamlagain@helsinki.fi 19 
E-mail addresses of co-authors: 20 
paulina.deptula@helsinki.fi; minnamari.edelmann@helsinki.fi; 21 
susanna.kariluoto@helsinki.fi; franck.grattepanche@yoplait.fr; 22 
christophe.lacroix@hest.ethz.ch; pekka.varmanen@helsinki.fi; 23 
vieno.piironen@helsinki.fi  24 
 25 
 26 
 27 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
ABSTRACT  28 
Propionibacterium freudenreichii is the only generally recognized safe (GRAS) 29 
bacterium known to synthesize active vitamin B12 and offers previously untapped 30 
potential for naturally fortifying foods with vitamin B12. Biosynthesis of the 31 
lower ligand 5,6-dimethylbenizimidazole (DMBI) is often a key limiting factor in 32 
the production of active vitamin B12 in Propionibacteria. Here, we studied the 33 
effect of the natural food-grade precursors of DMBI [riboflavin (RF) and 34 
nicotinamide (NAM)] on vitamin B12 production by 27 P. freudenreichii and 3 35 
Propionibacterium acidipropionici strains in whey-based medium. We employed 36 
sensitive and selective UHPLC and LC–MS/MS to confirm and quantify the 37 
synthesized vitamin B12. In 12 P. freudenreichii strains, co-supplementation with 38 
RF (40 µM) and NAM (27 mM) increased the volumetric yield of vitamin B12 up 39 
to 4-fold compared to the control cultures. For the majority of these strains, the 40 
production level with RF and NAM exceeded the yield obtained with DMBI 41 
supplementation (100 µM). The significant positive correlation between RF 42 
consumption and vitamin B12 production suggests that RF is proportionally 43 
directed towards vitamin B12 biosynthesis. This study shows that the availability 44 
of RF and NAM enhances the production of active vitamin B12 by P. 45 
freudenreichii in a strain-dependent manner. 46 
 47 
Keywords: Vitamin B12; Propionibacterium freudenreichii; fermentation; 48 
riboflavin; nicotinamide 49 
 50 
 51 
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1 Introduction 53 
Propionibacteria are among the few bacteria and archaea that synthesize 54 
vitamin B12 forms that are active for humans (hereafter called active B12) 55 
(Martens, Barg, Warren, & Jahn, 2002). The use of Propionibacterium 56 
freudenreichii in foods is currently limited to the manufacture of Swiss-type 57 
cheeses primarily for the characteristic eyes and typical cheese flavour (Thierry et 58 
al., 2011). As the only producer of active B12 that is safe for use in food (EFSA, 59 
2009), this bacterium could be utilized for the in situ B12 fortification of foods 60 
and food ingredients that lack or are deficient in vitamin B12 (Hugenholtz & 61 
Smid, 2002). Genetically engineered strains of P. freudenreichii are used in the 62 
commercial production of B12 in the pharmaceutical industry (Thierry et al., 63 
2011).  64 
The lower α-ligand of B12 (5,6-dimethylbenzimidazole, DMBI) plays an 65 
important role in the absorption of B12 in humans by enabling selective binding 66 
of the vitamin to the intrinsic factor (a B12 transporter glycoprotein) (Alpers & 67 
Russel-Jones, 1999; Andrews, Pratt, & Brown, 1991; Nielsen, Rasmussen, 68 
Andersen, Nexø, & Moestrup, 2012). For example, B12 with DMBI as the lower 69 
ligand has a 500-fold higher affinity for the intrinsic factor than pseudovitamin 70 
B12, which has adenine as the lower ligand (Stupperich & Nexø, 1991). Several 71 
microorganisms synthesize cobamides with other benzimidazoles, adenine or 72 
phenols as the lower ligand (Watanabe, Yabuta, Tanioka, & Bito, 2013). These 73 
compounds function as cofactors for the B12-dependent enzymes in these 74 
organisms (Taga & Walker, 2008) but are not recognized by human intrinsic 75 
factor (Stupperich & Nexø, 1991).  76 
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P. freudenreichii primarily synthesizes active B12 forms with DMBI as the 77 
lower ligand and adenosyl or methyl groups as the upper ligand 78 
(adenosylcobalamin and methylcobalamin) but may also synthesize small 79 
amounts of other cobamides, including pseudovitamin B12 (Quesada-Chanto et 80 
al., 1998; Renz, 1999; Vorobjeva, 1999). Some bacteria (e.g., Lactobacillus 81 
reuteri) exclusively synthesize pseudovitamin B12 even when grown with DMBI 82 
supplementation (Crofts, Seth, Hazra, & Taga, 2013; Santos et al., 2007). In a 83 
recent study, P. freudenreichii was shown to preferentially produce active B12 in 84 
a process that was guided by the biosynthesis of DMBI (Deptula et al., 2015). 85 
When the availability of DMBI was restricted and therefore no active vitamin 86 
could be synthesised, P. freudenreichii mostly accumulated incomplete cobamide 87 
and only a low level of pseudovitamin B12, even when supplemented with 88 
adenine (Deptula et al., 2015). The clear preference for the incorporation of 89 
DMBI as the lower ligand makes P. freudenreichii an ideal candidate for 90 
exploitation in the fermentation fortification of foods with the active B12 vitamin.  91 
The complete DMBI biosynthesis pathway in aerotolerant Propionibacteria 92 
was unclear for a long time. Taga, Larsen, Howard-Jones, Walsh, & Walker (2007) 93 
showed that the BluB enzyme from the soil bacterium Sinorhizobium meliloti was 94 
responsible for DMBI synthesis from a reduced flavin mononucleotide in an 95 
oxygenated environment. The first genome sequence of P. freudenreichii subsp. 96 
shermanii (strain CIRM-BIA1) revealed the presence of a bluB homologue (the 97 
fusion gene bluB/cobT2) (Falentin et al., 2010). Recently (Deptula et al., 2015), 98 
the BluB/CobT2 fusion enzyme from P. freudenreichii DSM 4902 was 99 
heterologously expressed, purified and characterized. The enzyme was confirmed 100 
to be responsible for the synthesis of DMBI from the reduced flavin 101 
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mononucleotide and its activation into the nucleotide ready for attachment as a 102 
lower ligand of active B12 (Deptula et al., 2015). Flavin mononucleotide and 103 
flavin-adenine dinucleotide are derived from riboflavin (RF), which together with 104 
RF are collectively known as vitamin B2. 105 
Natural strains of Propionibacteria differ greatly in their ability to synthesize 106 
B12 (Hugenschmidt, Schwenninger, Gnehm, & Lacroix, 2010). The B12 yield 107 
from P. freudenreichii is dependent upon the availability of cobalt and DMBI 108 
(Hugenschmidt, Schwenninger, & Lacroix, 2011). Earlier studies with P. 109 
freudenreichii cell homogenates showed that DMBI was synthesized from RF 110 
(Lingens, Schild, Vogler, & Renz, 1992; Renz & Weyhenmeyer, 1972) and that 111 
its biosynthesis was stimulated by nicotinamide (NAM) (Hörig & Renz, 1980). 112 
However, the effect of RF and NAM supplementation on B12 production by 113 
Propionibacteria has not been studied. DMBI is added to bacterial fermentations 114 
in the pharmaceutical industry to increase B12 yields (Martens et al., 2002); 115 
however, this process is not possible in natural fortifications. DMBI should be 116 
substituted with compounds approved for use in food (i.e., RF and NAM) or with 117 
food components rich in these vitamins to enhance B12 production. 118 
Therefore, the aim of the present work was to study the influence of RF and 119 
NAM on B12 production by several Propionibacteria strains in whey-based 120 
medium (WBM). Ultra-high performance liquid chromatography (UHPLC) and 121 
liquid chromatography–tandem mass spectrometry (LC–MS/MS) were employed 122 
for the accurate identification and quantification of synthesized B12 under the 123 
influence of the B12 precursors. 124 
 125 
2 Materials and methods 126 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
2.1 Chemicals and materials 127 
Cyanocobalamin was obtained from Supelco (Bellefonte, USA) and ethanol 128 
was obtained from Altia (Rajamäki, Finland). Sodium hydroxide, acetic acid, 129 
dipotassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium 130 
sulphate heptahydrate, manganese(II) sulphate monohydrate and granulated yeast 131 
extract were purchased from Merck (Darmstadt, Germany). Sodium cyanide, 132 
acetonitrile (HPLC grade), trifluoroacetic acid (TFA), formic acid, sodium D/L-133 
lactate syrup (60% w/w) and Tween 80 were obtained from Sigma-Aldrich 134 
(Steinheim, Germany). RF, NAM and cobalt(II) chloride hexahydrate were 135 
purchased from Sigma-Aldrich, and DMBI was obtained from Merck. Water 136 
(hereafter called MilliQ water) was produced by the MilliQ Plus system (0.22 µm, 137 
≥ 18.2 MΩ cm; Millipore Corporation, Bedford, MA, USA). 138 
 139 
2.2 Propionibacteria strains 140 
A collection of 27 P. freudenreichii and three P. acidipropionici strains were 141 
studied. Twenty P. freudenreichii strains (256‒265, 283‒292) with probable dairy 142 
origins were obtained from the culture collection of Valio Ltd. (Helsinki, Finland). 143 
Two type strains (P. freudenreichii subsp. shermanii DSM 4902 and P. 144 
freudenreichii subsp. freudenreichii DSM 20271) with dairy origins were 145 
obtained from DSMZ (Braunschweig, Germany) and named 281 and 282, 146 
respectively. One P. freudenreichii strain (266) was an isolate from a cheese 147 
starter culture (Chamlagain, Edelmann, Kariluoto, Ollilainen, & Piironen, 2015). 148 
Four P. freudenreichii strains (274‒277) and the P. acidipropionici strains (278‒149 
280) with probable cereal origins were obtained from the culture collection of 150 
Polttimo Ltd. (Lahti, Finland).  151 
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 152 
2.3 Growth media 153 
WBM (pH 6.4) was prepared according to Hugenschmidt et al. (2010) using 154 
demineralized whey powder (Demi 50; Valio Ltd., Helsinki, Finland) instead of 155 
ultra-filtered whey permeate. The composition per L of the medium was 60 g of 156 
whey extract (from whey powder), 10 g of yeast extract, 13 g of sodium D/L-157 
lactate syrup (60% w/w), 0.1 g of Tween 80, 0.2 g of magnesium sulphate, 0.02 g 158 
of manganese(II) sulphate, and 100 mL of 1 M potassium phosphate buffer. To 159 
prepare the whey extract, an acidified whey powder suspension (85.7 g/L; pH 5.0) 160 
was autoclaved (121 °C; 15 min) and paper-filtered (10‒15 µm). The whey extract 161 
(700 mL) was mixed with a Tween 80-Mg-Mn solution (150 mL) and autoclaved 162 
separately from the yeast extract, lactate and phosphate buffer solution (150 mL; 163 
pH 6.6). Immediately prior to usage, the two parts were mixed to obtain 1 L of 164 
medium. A filter-sterilized (0.2 µm) solution of cobalt chloride was added to the 165 
medium (5 mg/L). The propionic agar medium was composed (per L) of 5 g of 166 
tryptone (Sigma-Aldrich), 10 g of yeast extract (Becton, Dickinson) and 14 mL of 167 
sodium lactate with the pH adjusted to 7.3 prior to autoclaving. 168 
 169 
2.4 Precursor supplementation 170 
Each strain was cultivated in triplicate in WBM with and without RF (40 171 
µM), the co-addition of RF (40 µM) and NAM (27 mM) or DMBI (100 µM) 172 
(concentrations based on Hörig & Renz, 1980; Hugenschmidt et al., 2011). The 173 
time effect of RF and NAM supplementation (on days 0, 3 or 6) on B12 174 
production was studied with strains 256 and 266. Finally, RF or RF and NAM 175 
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were added on day 0 and DMBI was supplemented on day 6 per Hugenschmidt et 176 
al. (2010). The stock solutions were prepared in MilliQ water and filter-sterilized.  177 
 178 
2.5 Culture preparation and fermentation  179 
Cultures of strains cryopreserved (−80 °C) in glycerol were propagated on 180 
propionic agar medium and incubated anaerobically (Anaerocult C; Merck, 181 
Darmstadt, Germany) for 3‒4 days at 30 °C. Three individual colonies of each 182 
strain were transferred into 5 mL of WBM and incubated for 3‒4 days at 30 °C 183 
under anaerobic conditions. The cultures were sub-cultured three times prior to 184 
inoculation. To determine B12 production by the strains, 20 mL of WBM was 185 
inoculated at 1% (v/v) and incubated at 30 °C for 72 h under anaerobic conditions, 186 
followed by 96 h of aerobic incubation (with the tubes slightly opened under 187 
sterile conditions to allow air in and then closed again) under shaking conditions 188 
(150 rpm; Certomat H, Sartorious, France) (Hugenschmidt et al., 2010).  189 
The fermented broths obtained after 168 h of incubation were centrifuged 190 
(12,000 x g; 10 min) and the supernatants were collected. The cell pellets were re-191 
suspended in 10 mL of PBS buffer (pH 7.3; Oxoid, Hampshire, UK) and 192 
recovered by centrifugation. The cell biomasses in the tubes were weighed and 193 
stored at −20 °C prior to B12 analysis. The pH of the supernatants was measured; 194 
then, the supernatants were syringe-filtered (0.2 µm; Pall, MI, USA) and stored at 195 
−20 °C prior to analysis for residual RF, lactose and acids. The progress of 196 
fermentation was monitored at 72 h and 168 h by measuring the optical density 197 
(600 nm; OD600) with a Novespec II spectrophotometer (Amersham Pharmacia 198 
Biotech, NJ, USA). The pH was recorded with a pH metre (Radiometer Analytical, 199 
Lyon, France).  200 
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 201 
2.6 Vitamin B12 analysis  202 
The B12 content in the cell pellets was extracted in cyano form and analysed 203 
using the previously reported extraction and UHPLC methods (Chamlagain et al., 204 
2015). Briefly, 0.1–0.2 g of cell pellet was extracted with a pH 4.5 extraction 205 
buffer (8.3 mM sodium hydroxide and 20.7 mM acetic acid) in the presence of 206 
sodium cyanide to obtain 25 mL of the extract. The extract was analysed with a 207 
Waters Acquity UPLC system (Milford, MA, USA) equipped with a photodiode 208 
array detector (PDA; 210–600 nm) using an Acquity HSS T3 C18 column (2.1 × 209 
100 mm, 1.8 µm). The mobile phase was a gradient flow of MilliQ water and 210 
acetonitrile both containing 0.025% TFA. The chromatogram was obtained by 211 
recording the absorbance at 361 nm. Six cyanocobalamin standards (0.015‒0.75 212 
ng/µL) were injected (10 µL in duplicate) to create a calibration curve for each 213 
sample set. The volumetric B12 yield (µg/mL WBM) and cellular B12 yield (µg/g 214 
wet cell mass) for each strain are reported as an average of three biological 215 
replicate fermentations. 216 
The identity of the cobamide in the extracts was confirmed with mass 217 
spectrometry using an Esquire-LC quadrupole ion trap mass spectrometer with an 218 
electrospray ionization (ESI) interface (Bruker Daltonics, Bremen, Germany) in 219 
positive ion mode as previously described (Chamlagain et al., 2015). The mobile 220 
phase for LC–MS contained 0.1% formic acid. Briefly, ions with an m/z range of 221 
900‒1400 were scanned, and tandem mass spectrometry (MS/MS) was performed 222 
for ions with m/z 1356 ([M+H]+ of cyanocobalamin) using helium as the collision 223 
gas. The instrumental settings were as follows: nebulizer (nitrogen) 50.0 psi, dry 224 
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gas (nitrogen) 8.0 L/min, dry temperature 300 °C, capillary 4500 V, end plate 225 
offset −250 V and trap drive 84. 226 
 227 
2.7 Measurement of riboflavin content 228 
Vitamin B2 was extracted as RF from the control and fermented WBM 229 
without any supplementation and analysed using the European standard method 230 
(EN 14152:2014) after optimization for UHPLC. The supernatant (0.5 mL) was 231 
mixed with 15 mL of 0.1 M hydrochloric acid and extracted in a boiling water 232 
bath for 60 min. After cooling, the extract was adjusted to pH 4.5 with 2.5 M 233 
sodium acetate and incubated (37 °C; 24 h) with Taka-Diastase (50 mg; Pfaltz and 234 
Bauer, CT, USA) and β-amylase (5 mg; Sigma-Aldrich). The analysis was 235 
performed with a Waters UPLC system equipped with a fluorescence detector 236 
using a Waters Acquity BEH C18 column (2.1 mm × 100 mm; 1.7 µm particles). 237 
The mobile phase contained 20 mM ammonium acetate dissolved in 30% aqueous 238 
methanol and eluted at a constant flow of 0.2 mL/min. The excitation and 239 
emission wavelengths were set at 444 nm and 520 nm, respectively. An external 240 
calibration curve was obtained by injecting six RF standards (0.01–1.0 ng/µL) in 241 
10 µL in duplicate for the quantitation.  242 
 243 
2.8 Analysis of sugar and acids  244 
The cell-free fermented WBM and control media were appropriately diluted 245 
with MilliQ water and filtered (0.45 µm; Pall, USA). Lactose, lactic acid and the 246 
metabolites propionic acid and acetic acid in the samples were quantified with the 247 
HPLC method reported by Hugenschmidt et al. (2010). The analysis was 248 
performed using an HPLC system equipped with a pump (Waters 515), an 249 
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autosampler, a UV detector (Waters 717) and a refractive index detector (HP 250 
1047A, HP, USA) on an Aminex HPX-87H column (7.8 × 300 mm, 9 µm 251 
particles; Bio-Rad, USA). 252 
 253 
2.9 Statistical analysis  254 
The average B12 yields (µg/mL) and cellular B12 yields (µg/g wet cell mass) 255 
for each strain following supplementation with B12 precursors were compared by 256 
one way analysis of variance (ANOVA) and Tukey’s post hoc test using SPSS 22 257 
(IBM Corporation, NY, USA). A p value < 0.05 was considered statistically 258 
significant.  259 
 260 
3 Results and discussion  261 
3.1 Growth characteristics  262 
The final cell densities measured as the optical density at 600 nm (OD600) 263 
varied greatly between strains, ranging from OD600 = 1.2 to OD600 = 17.8 in un-264 
supplemented WBM (Fig. 1A). A low (< 5) final OD600 value coincided with a 265 
high (> 6) final pH (Fig. 1B) that was indicative of the strain’s inability to 266 
metabolize lactose in the medium. These strains relied solely on sodium lactate as 267 
a carbon source, which was also reflected in the smaller amounts of propionic and 268 
acetic acids produced by these strains (Supplemental Fig. 1A). In P. 269 
freudenreichii, lactose utilization is strain dependent and is one of the two 270 
phenotypic criteria (together with nitrate reductase activity) used to divide the 271 
species into two subspecies: subsp. freudenreichii, which is lactose negative (type 272 
strain 282), and subsp. shermanii, which is lactose positive (type strain 281) 273 
(Thierry et al., 2011). Five of the strains growing to higher final OD600 values 274 
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(261, 262, 264, 266 and 289) produced slime during fermentation, which 275 
prevented the isolation of cells from the final culture as a pellet. P. freudenreichii 276 
strains are known to produce exopolysaccharides consisting of glucose, galactose 277 
or other sugars depending on the strain (Darilmaz & Gumustekin, 2012; 278 
Nordmark, Yang, Huttunen, & Widmalm, 2005; Thierry et al., 2011). Therefore, 279 
the measured final OD600 values for these slime-producing strains most likely do 280 
not reflect the final cell densities.  281 
The effect of supplementation on growth was strain- and supplement-282 
dependent. Generally, supplementation did not restrict the growth of the strains; 283 
however, co-supplementation with RF and NAM together had a stimulating effect 284 
on the growth of some strains (Fig. 1A), with a few producing slime in the 285 
medium. Nevertheless, these supplements did not affect the final pH values of the 286 
cultures (Fig. 1B), suggesting that there was no immediate effect of carbon 287 
metabolism on acid production (Supplemental Fig. 1B). 288 
 289 
3.2 Confirmation of active B12 production with and without supplements  290 
The UHPLC–UV/Vis and LC–MS/MS analyses showed that all 27 studied 291 
strains of P. freudenreichii produced active B12 in native WBM and with RF, RF 292 
and NAM or DMBI supplementation. The cobamide extracted in its cyano form 293 
from the cell biomasses of the strains grown in WBM and DMBI-supplemented 294 
WBM eluted with the same retention time as cyanocobalamin (Fig. 2A) and had a 295 
PDA spectrum (210‒600 nm) identical to cyanocobalamin (data not shown). The 296 
MS/MS spectra of the cobamide peak (Figs. 2C and 2D) were identical to the 297 
fragmentation profile of cyanocobalamin (Fig. 2B). An analysis of the major 298 
fragment ions (m/z 1209, 1124, 997 and 912 corresponding to [M+H−DMBI]+, 299 
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[M+H−DMBI−CN−Co]+, [M+H−DMBI−sugar−phosphate]+ and 300 
[M+H−DMBI−sugar−phosphate−CN−Co]+, respectively) confirmed that cobamide 301 
contained DMBI as the lower ligand as reported previously (Chamlagain et al., 302 
2015). Similarly, the extracted cobamide from media supplemented with RF or 303 
RF and NAM was confirmed to be cyanocobalamin. In contrast, the 304 
cyanocobalamin peak was detected in the cell extracts of the P. acidipropionici 305 
strains only when grown with DMBI. The peak was not identified in the P. 306 
acidipropionici strains grown with RF or with RF and NAM, confirming the 307 
inability of these strains to synthesize DMBI de novo for active B12 production. 308 
DMBI is usually added during commercial B12 production; however, its use is 309 
not desirable for in situ B12 production in foods or for the production of B12 310 
bioingredients with minimal downstream processing (Hugenschmidt et al., 2011), 311 
thereby rendering P. freudenreichii a more suitable candidate for these 312 
applications. However, the yield of active B12 and the response to 313 
supplementation was strain dependent (Sections 3.3‒3.5). 314 
  315 
3.3 Effect of riboflavin and nicotinamide supplementation time on B12 production 316 
The effect of the RF and NAM supplementation time on B12 production was 317 
tested with two P. freudenreichii strains (Fig. 3). Strain 266 produced 2.4-fold 318 
more B12 when the supplementation was performed on day 0 or day 3 compared 319 
to day 6. In contrast, the B12 yield with strain 256 was not improved by RF and 320 
NAM (p > 0.05) but was markedly increased (by 80%) by DMBI supplementation. 321 
The results suggest that the availability of RF and NAM during the early stage of 322 
fermentation improves B12 production from certain P. freudenreichii strains. This 323 
finding is useful for the in situ B12 fortification of foods because native RF and 324 
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niacin in food matrices are accessible from the beginning of the fermentation. In 325 
contrast, DMBI is preferably supplied 24 h before the termination of fermentation 326 
in industrial B12 production (Hugenholtz, Hunik, Santos, & Smid, 2002; Murooka, 327 
Piao, Kiatpapan, & Yamashita, 2005) because early addition of DMBI is thought 328 
to reduce the growth of P. freudenreichii and decrease the B12 yield (Marwaha, 329 
Sethi, & Kennedy, 1983). Based on the results of this comparison, RF and NAM 330 
were supplemented at the beginning of the fermentation in the latter experiment, 331 
whereas DMBI was added on day 6 of the fermentation. 332 
 333 
3.4 B12 production in WBM without supplementation 334 
The B12 yield in WBM varied greatly between the studied P. freudenreichii 335 
strains (Figs. 4A and 4B), suggesting strain-dependent B12 production. The 336 
volumetric and cellular B12 yields ranged from 0.45 to 3.35 µg/mL (Fig. 4A) and 337 
25 to 204 µg/g wet cell mass (Fig. 4B), respectively. For the six strains (261, 262, 338 
264, 265, 266 and 289) that produced slime, the cellular B12 yields were not 339 
accurate and therefore were not included in Fig. 4B. Because the produced B12 340 
accumulate intracellularly in Propionibacteria, the volumetric B12 yield (µg/mL) 341 
is directly affected by the amount of cell biomass obtained (data not shown) and 342 
the cellular B12 yield (Fig. 4B). Frequently, higher cellular B12 yields were 343 
obtained for strains growing to lower final OD600 values (Fig. 1A) that did not 344 
metabolize lactose while the pH of the medium remained >6 (Fig. 1B). For 345 
Propionibacteria, the culture medium pH greatly influences growth and B12 346 
biosynthesis, with pH 6‒7 optimal for growth (Hsu & Yang, 1991; Vorobjeva, 347 
1999) and growth ceasing below pH 5 (Hettinga & Reinbold, 1972). Therefore, 348 
the medium is usually maintained at approximately pH 7 during industrial B12 349 
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production by neutralizing the acids with alkali agents (Martens et al., 2002). 350 
However, the control of pH to improve in situ B12 production in food matrices is 351 
not preferred.  352 
 353 
3.5 Effect of riboflavin and nicotinamide vs DMBI supplementation on B12 354 
production 355 
RF supplementation alone did not increase B12 production by the strains (p > 356 
0.05; Figs. 4A and 4B). This result is likely due to the relatively high level (2.5 357 
µg/mL) of RF present in the WBM. We compared the consumption of native RF 358 
from the medium by the studied strains. The analyses revealed that the P. 359 
freudenreichii strains consumed 25% to 85% of the RF present in the WBM, 360 
whereas the P. acidipropionici strains did not use the RF from the medium. 361 
Indeed, a significant positive correlation (r = 0.84) was observed when RF 362 
consumption was compared with B12 production (Fig. 5). 363 
Supplementation of the WBM with both RF and NAM increased both the 364 
volumetric and cellular B12 yields in several strains (p < 0.05; Figs. 4A and 4B), 365 
including the P. freudenreichii subsp. shermanii type strain (281). Notably, this 366 
enhancement in volumetric B12 production was more effective than DMBI 367 
supplementation in seven of the strains (261‒264, 266, 284 and 285) (Fig. 4A). To 368 
the best of our knowledge, the enhancing effect of RF and NAM on B12 369 
biosynthesis by metabolizing P. freudenreichii cell has not been reported 370 
previously. For four strains (274, 275, 276 and 286) and the P. freudenreichii 371 
subsp. freudenreichii type strain (282), the addition of RF and NAM significantly 372 
decreased the volumetric B12 yield (p < 0.05) compared to the yield in WBM.  373 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
DMBI supplementation enhanced the volumetric and cellular B12 yields (p < 374 
0.05) of seven (256, 257, 281, 283, 288, 289 and 290) and five (256, 257, 281, 375 
288 and 290) P. freudenreichii strains, respectively (Figs. 4A and 4B). The 376 
increase in the volumetric yield ranged from 18% for strain 257 to 280% for type 377 
strain 281. The enhancement in the cellular B12 yield was most effective for 378 
strain 281, with a 3.2-fold higher concentration observed in the cells with DMBI 379 
supplementation compared to the control culture (Fig. 4B). Altogether, these 380 
results revealed that the availability of exogenous DMBI was not limiting for B12 381 
production under the conditions used for specific P. freudenreichii strains. 382 
Therefore, we speculated that the P. freudenreichii strains that did not respond to 383 
DMBI supplementation were unable to uptake DMBI from the environment. The 384 
DMBI transporter in P. freudenreichii has not been identified to date. 385 
By including a number of strains, the present study provides evidence in 386 
support of the current understanding that P. freudenreichii synthesizes DMBI 387 
from RF (Hörig & Renz, 1977; Renz & Weyhenmeyer, 1972; Vorobjeva, 1999). 388 
The results also indicate that the efficiency of DMBI synthesis in P. 389 
freudenreichii is strain dependent. All three P. acidipropionici strains studied 390 
were dependent on exogenous DMBI to produce even traces of active B12 (Figs 391 
4A and 4B), suggesting the lack of the DMBI biosynthesis pathway in P. 392 
acidipropionici. Indeed, genomic data (Parizzi et al., 2012) indicate that P. 393 
acidipropionici lacks the bluB/cobT2 gene responsible for DMBI biosynthesis and 394 
activation in P. freudenreichii (Deptula et al. 2015).  395 
In P. freudenreichii, nicotinate mononucleotide (NaMN) is the preferred 396 
substrate for the activation of DMBI into α-ribazole-phosphate by the 397 
BluB/CobT2 enzyme of the nucleotide loop assembly (Deptula et al., 2015; 398 
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Friedmann & Harris, 1965). NAM was rapidly converted into nicotinate in studies 399 
on the DMBI-forming system using P. freudenreichii cells and cell homogenates, 400 
suggesting that nicotinate was the actual stimulant of the DMBI-forming system 401 
in P. freudenreichii (Hörig & Renz, 1980). In line with this finding, NAM was 402 
found to be completely converted into nicotinate at the end of fermentation (data 403 
not shown). Thus, the synthesis or regeneration of NaMN could have been 404 
enhanced by the presence of excess nicotinate. Additionally, nicotinate might 405 
allosterically regulate the enzyme involved in DMBI biosynthesis (Chen, Ailion, 406 
Weyand, & Roth, 1995), which would be consistent with the greater effect of RF 407 
and NAM supplementation over DMBI supplementation for the majority of the 408 
strains. However, this hypothesis needs to be explored in follow-up studies.  409 
In this study, the highest volumetric B12 yields (obtained with strain 288) 410 
with and without DMBI supplementation were 5.3 µg/mL and 3.3 µg/mL, 411 
respectively (Fig. 4A). The highest yield obtained with co-supplementation with 412 
RF and NAM was 4.2 µg/mL (with strain 284). All of these values clearly exceed 413 
those reported in a previous study using 100 natural strains of Propionibacteria, 414 
where the maximum yield in DMBI-supplemented whey permeate was 2.5 µg/mL 415 
(Hugenschmidt et al., 2010).  416 
 417 
4 Conclusion 418 
We used UHPLC–UV/Vis and LC–MS/MS and showed that all 27 P. 419 
freudenreichii strains studied synthesized active vitamin B12 in whey-based 420 
medium without DMBI supplementation, whereas the P. acidipropionici strains 421 
were able to produce traces of B12 only when provided exogenous DMBI. B12 422 
production by the P. freudenreichii strains was strain dependent. The yield from 423 
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several strains was markedly increased by the addition of the lower ligand 424 
precursors. The volumetric B12 yield increased up to 4-fold with co-425 
supplementation with RF and NAM, and for a number of strains the yield was 426 
comparable or even higher than that achieved with DMBI. A significant positive 427 
correlation between RF consumption and B12 production confirmed that the 428 
DMBI ligand of B12 in P. freudenreichii was synthesized from RF. The increased 429 
yield obtained with RF and NAM co-supplementation clearly indicates enhanced 430 
de novo synthesis of DMBI and its activation into the nucleotide. The present 431 
study suggests that improved in situ production of B12 in foods is possible 432 
without the need for DMBI supplementation by selecting a P. freudenreichii strain 433 
that better responds to RF and NAM. 434 
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Figure captions: 550 
Fig. 1. Effect of riboflavin (RF), co-supplementation with RF and nicotinamide 551 
(NAM), and DMBI on the optical density (4A) and pH (4B) of whey-based 552 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
medium (WBM) fermented with 30 Propionibacterium strains. DMBI = 5,6-553 
dimethylbenzimidazole. 554 
Fig. 2. A) Example UHPLC–UV chromatograms of the cyanocobalamin standard 555 
and extracts of the cell biomass obtained from 168-h fermented whey-based 556 
medium (WBM) and from WBM supplemented with DMBI. LC–MS/MS spectra 557 
of the cyanocobalamin standard (B) and the cobamide in cell extracts eluting at 558 
the retention time of cyanocobalamin (3.27 min) from cell biomasses grown in 559 
WBM (C) and WBM with DMBI supplementation (D). DMBI = 5,6-560 
dimethylbenzimidazole. 561 
Fig. 3. Effect of the riboflavin (RF) and nicotinamide (NAM) addition time (days 562 
0, 3 or 6) on vitamin B12 production by P. freudenreichii strains 256 and 266 in 563 
whey-based medium (WBM). The results are expressed as the mean ± standard 564 
deviation (n = 3), and columns with different letters differ significantly (p < 0.05). 565 
DMBI = 5,6-dimethylbenzimidazole.  566 
Fig. 4. Effect of riboflavin (RF), RF and nicotinamide (NAM), and DMBI 567 
supplementation on the volumetric vitamin B12 yield (µg/mL) (Fig. 4A) and 568 
cellular B12 yield (µg/g wet cell mass)
 
(Fig. 4B) by 30 Propionibacterium strains 569 
in whey-based medium (WBM). DMBI = 5,6-dimethylbenzimidazole. Error bars 570 
represent the standard deviations of three biological replicate fermentations. 571 
Strains 256 and 266 were not studied with RF supplementation. 572 
*
The B12 per gram of cells data are not shown for six strains (261, 262, 264, 265, 573 
266 and 289) that were difficult to isolate as cell pellets.  574 
Fig. 5. Correlation between riboflavin (RF) consumption and vitamin B12 575 
production by 30 strains of Propionibacteria in whey-based medium (WBM). 576 
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• UHPLC–UV/Vis–MS confirmed active vitamin B12 production by 
Propionibacterium freudenreichii strains. 
• B12 yield was strain dependent. 
• Supplementation with riboflavin and nicotinamide increased B12 yield up 
to 4-fold. 
• Significant positive correlation was observed between riboflavin 
consumption and B12 production. 
• Increasing in situ B12 production is possible with added natural precursors 
in food matrices. 
